Overview on microfluidics devices for monitoring brain disorder biomarkers

Nix, Cindy; Ghassemi, Maryam; Crommen, Jacques; Fillet, Marianne

doi:10.1016/j.trac.2022.116693

Request a copy

Article (Scientific journals)

Overview on microfluidics devices for monitoring brain disorder biomarkers

Nix, Cindy; Ghassemi, Maryam; Crommen, Jacques et al.

2022 • In TrAC: Trends in Analytical Chemistry, 155, p. 116693

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/302380

DOI
10.1016/j.trac.2022.116693

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S0165993622001765-main-1.pdf

Publisher postprint (1.66 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Biomarker detection; Neurological disorder; Organ-on-a-chip; Brain disorders; Microfluidics devices

Abstract :

[en] Neurological disorders are one of the leading causes of disability and death worldwide. The complexity of the human brain and therefore the significant structural gap between animal models and humans, all serve to hinder translational success. Recent advances in microfluidic devices and human organ-on-a-chip systems have provided new opportunities to study and monitor such diseases with the benefits of precise control, lower sample requirement and reagent consumption, cost-effectiveness and high throughput screening. Combined with biosensors, mass spectrometry or automatic imaging systems, they have emerged as a unique way to facilitate personalized medicine. To obtain relevant and reliable information, it is crucial to address the different challenges specific to each type of microfluidics device. In the following review, the discussion is focused on the technical setup of microfluidic devices for the detection of brain disorder biomarkers and on the microfluidics strategies that are applied to monitor neurological diseases. In the last section, we also discuss limitations, challenges and regulatory requirements that remain to be considered in future experiments.

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Nix, Cindy ^✱; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments

Ghassemi, Maryam ^✱; University of Liège (ULiège), CIRM, Laboratory for the Analysis of Medicines, Liège, Belgium

Crommen, Jacques ; Université de Liège - ULiège > Département de pharmacie

Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments

^✱ These authors have contributed equally to this work.

Language :

English

Title :

Overview on microfluidics devices for monitoring brain disorder biomarkers

Publication date :

October 2022

Journal title :

TrAC: Trends in Analytical Chemistry

ISSN :

0165-9936

eISSN :

1879-3142

Publisher :

Elsevier B.V.

Volume :

155

Pages :

116693

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://api.elsevier.com/content/article/PII:S0165993622001765?httpAccept=text/xml

Funders :

FEDER - Fonds Européen de Développement Régional
F.R.S.-FNRS - Fonds de la Recherche Scientifique

Funding text :

The authors want to thank the National Fund for Scientific Research (F. N. R. S.) for its financial support. Walloon Region of Belgium and EU Commission (project FEDER-PHARE) and FNRS through Chimic EOS project are also acknowledge.

Available on ORBi :

since 08 May 2023

Statistics

Number of views

37 (3 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Feigin, V.L., et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18 (2019), 459–480, 10.1016/S1474-4422(18)30499-X.
Holloway, P.M., et al. Advances in microfluidic in vitro systems for neurological disease modeling. J. Neurosci. Res. 99 (2021), 1276–1307, 10.1002/jnr.24794.
Staicu, C.E., et al. Lab-on-a-chip platforms as tools for drug screening in neuropathologies associated with blood–brain barrier alterations. Biomolecules, 11, 2021, 10.3390/biom11060916.
Berlanda, S.F., et al. Recent advances in microfluidic technology for bioanalysis and diagnostics. Anal. Chem., 2021, 10.1021/acs.analchem.0c04366.
Tian, C., et al. Recent advances in microfluidic technologies for organ-on-a-chip. TrAC Trends Anal. Chem. (Reference Ed.) 117 (2019), 146–156, 10.1016/j.trac.2019.06.005.
Low, L.A., et al. Tagle, Organs-on-chips: into the next decade. Nat. Rev. Drug Discov. 20 (2021), 345–361, 10.1038/s41573-020-0079-3.
Bang, S., et al. Emerging brain-pathophysiology-mimetic platforms for studying neurodegenerative diseases: brain organoids and brains-on-a-chip. Adv. Healthc. Mater., 10, 2021, 10.1002/adhm.202002119.
Strimbu, K., Tavel, J., What are Biomarkers?. Curr. Opin. HIV AIDS 5 (2010), 463–466, 10.1097/COH.0b013e32833ed177.
Gug, I.T., et al. Salivary biomarkers detection: analytical and immunological methods overview. TrAC Trends Anal. Chem. (Reference Ed.) 113 (2019), 301–316, 10.1016/j.trac.2019.02.020.
Wan, J., et al. Emerging roles of microfluidics in brain research: from cerebral fluids manipulation to brain-on-a-chip and neuroelectronic devices engineering. Chem. Rev., 2022, 10.1021/acs.chemrev.1c00480.
Brofiga, M., et al. On the road to the brain-on-a-chip: a review on strategies, methods, and applications. J. Neural. Eng., 18, 2021, 10.1088/1741-2552/ac15e4.
Bang, S., et al. Brain-on-a-chip: a history of development and future perspective. Biomicrofluidics, 13, 2019, 10.1063/1.5120555.
Ding, et al. Recent advances in droplet microfluidics. Anal. Chem., 92, 2020, 10.1021/acs.analchem.9b05047.
wen Liu, W., Zhu, Y., Development and application of analytical detection techniques for droplet-based microfluidics-A review. Anal. Chim. Acta 1113 (2020), 66–84, 10.1016/j.aca.2020.03.011.
Kaushik, A.M., et al. Droplet microfluidics for high-sensitivity and high-throughput detection and screening of disease biomarkers. Wiley Interdiscip. Rev. Nanomedicine Nanobiotechnology. 10 (2018), 1–30, 10.1002/wnan.1522.
Kopp, M.R.G., et al. Microfluidic shrinking droplet concentrator for analyte detection and phase separation of protein solutions. Anal. Chem. 92 (2020), 5803–5812, 10.1021/acs.analchem.9b05329.
Ngernsutivorakul, T., et al. In vivo chemical monitoring at high spatiotemporal resolution using microfabricated sampling probes and droplet-based microfluidics coupled to mass spectrometry. Anal. Chem. 90 (2018), 10943–10950, 10.1021/acs.analchem.8b02468.
Wuethrich, A., Quirino, J.P., A decade of microchip electrophoresis for clinical diagnostics – a review of 2008–2017. Anal. Chim. Acta 1045 (2019), 42–66, 10.1016/j.aca.2018.08.009.
Yu, S., et al. A novel method to predict protein aggregations using two-dimensional native protein microfluidic chip electrophoresis. Anal. Methods 8 (2016), 8306–8313, 10.1039/c6ay02011a.
Duarte-Junior, G.F., et al. Integrated microfluidic device for the separation, decomposition and detection of low molecular weight S-nitrosothiols. Analyst 144 (2019), 180–185, 10.1039/c8an00757h.
Roychoudhury, A., et al. A decoupler-free simple paper microchip capillary electrophoresis device for simultaneous detection of dopamine, epinephrine and serotonin. RSC Adv. 10 (2020), 25487–25495, 10.1039/d0ra03526b.
Gunawardhana, S.M., et al. Progress towards the development of a microchip electrophoresis separation-based sensor with electrochemical detection for on-line in vivo monitoring of catecholamines. Analyst, 145, 2020, 10.1039/c9an01980d.
Staal, S., et al. A versatile electrophoresis-based self-test platform. Electrophoresis 36 (2015), 712–721, 10.1002/elps.201400428.
Kubáň, P., Hauser, P.C., Evaluation of microchip capillary electrophoresis with external contactless conductivity detection for the determination of major inorganic ions and lithium in serum and urine samples. Lab Chip 8 (2008), 1829–1836, 10.1039/b802973c.
Shi, Y., et al. Application of microfluidics in immunoassay: recent advancements. 2021 J. Healthc. Eng., 2021, 10.1155/2021/2959843.
Han, K.N., et al. Microfluidic chips for immunoassays. Annu. Rev. Anal. Chem. 6 (2013), 119–141, 10.1146/annurev-anchem-062012-092616.
Van Thanh Nguyen, N., et al. Recent electrokinetic and microfluidic strategies for detection of amyloid beta peptide biomarkers: towards molecular diagnosis of Alzheimer's disease. Chem. Rec. 21 (2021), 149–161, 10.1002/tcr.202000103.
Mai, T.D., et al. Single-step immunoassays and microfluidic droplet operation: towards a versatile approach for detection of amyloid-β peptide-based biomarkers of Alzheimer's disease. Sensor. Actuator. B Chem. 255 (2018), 2126–2135, 10.1016/j.snb.2017.09.003.
Brazaca, L.C., et al., Moreto, J.R., Martín, A., Tehrani, F., Wang, J., Zucolotto, V., Colorimetric paper-based immunosensor for simultaneous determination of fetuin B and clusterin toward early Alzheimer's diagnosis. ACS Nano 13 (2019), 13325–13332, 10.1021/acsnano.9b06571.
Krausz, A.D., et al. A variable height microfluidic device for multiplexed immunoassay analysis of traumatic brain injury biomarkers. Biosensors 11 (2021), 1–17, 10.3390/bios11090320.
Schmidt-Speicher, L.M., Länge, K., Microfluidic integration for electrochemical biosensor applications. Curr. Opin. Electrochem., 29, 2021, 100755, 10.1016/j.coelec.2021.100755.
Cui, F., et al. Review—measurement and analysis of cancer biomarkers based on electrochemical biosensors. J. Electrochem. Soc., 167, 2020, 037525, 10.1149/2.0252003jes.
Li, Y., et al. Paper-based electrochemical biosensors for point-of-care testing of neurotransmitters. J. Anal. Test. 3 (2019), 19–36, 10.1007/s41664-019-00085-0.
Senel, M., et al. Microfluidic electrochemical sensor for cerebrospinal fluid and blood dopamine detection in a mouse model of Parkinson's disease. Anal. Chem. 92 (2020), 12347–12355, 10.1021/acs.analchem.0c02032.
De Oliveira, T.R., et al. Early diagnosis of Alzheimer's disease in blood using a disposable electrochemical microfluidic platform. ACS Sens. 5 (2020), 1010–1019, 10.1021/acssensors.9b02463.
Yan, et al. Advances in analytical technologies foe extracellular vesicles. Anal. Chem. 93 (2021), 4739–4774, 10.1021/acs.analchem.1c00693.
Albalawi, A.M., et al. Exosomes: isolation, characterization, and biomedical applications. Cell Biol. Int., 2021, 1807–1831, 10.1002/cbin.11620.
Xu, H., et al. Potential therapeutic applications of exosomes in different autoimmune diseases. Clin. Immunol. 205 (2019), 116–124, 10.1016/j.clim.2019.06.006.
Soltesz, B., et al. The role of exosomes in cancer progression. Int. J. Mol. Sci., 23, 2022, 10.3390/ijms23010008.
Martin-ventura, J.L., et al. Role of extracellular vesicles as potential diagnostic and/ or therapeutic biomarkers in chronic cardiovascular diseases. Front. Cell Dev. Biol. 10 (2022), 1–18, 10.3389/fcell.2022.813885.
Zhang, T., et al. The emerging role of exosomes in Alzheimer ’ s disease. Ageing Res. Rev., 68, 2021, 101321, 10.1016/j.arr.2021.101321.
Zhong, X., et al. Antidepressant paroxetine exerts developmental neurotoxicity in an iPSC-derived 3D human brain model. Front. Cell. Neurosci. 14 (2020), 1–11, 10.3389/fncel.2020.00025.
Zhang, N., et al. Role of exosomes in brain diseases. Front. Cell. Neurosci. 15 (2021), 1–14, 10.3389/fncel.2021.743353.
Gao, P., et al. Diagnostic and therapeutic potential of exosomes in neurodegenerative diseases. Front. Aging Neurosci., 13, 2021, 10.3389/fnagi.2021.790863.
Su, W., et al. Microfluidic strategies for label-free exosomes isolation and analysis. TrAC Trends Anal. Chem. (Reference Ed.) 118 (2019), 686–698, 10.1016/j.trac.2019.06.037.
Shao, H., et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. Commun. 138673 (2015), 1–9, 10.1038/ncomms7999.
Bark, J.M., et al. Isolation of circulating tumour cells in patients with glioblastoma using spiral micro fl uidic technology – a pilot study. Front. Oncol. 11 (2021), 1–10, 10.3389/fonc.2021.681130.
Jahromi, M., et al. Microfluidic brain-on-a-chip: perspectives for mimicking neural system disorders. Mol. Neurobiol. 56 (2020), 8489–8512, 10.1007/s12035-019-01653-2.
Amirifar, L., et al. Brain-on-a-chip: recent advances in design and techniques for microfluidic models of the brain in health and disease. Biomaterials, 2022, 121531, 10.1016/j.biomaterials.2022.121531.
Niculescu, A.G., et al. Fabrication and applications of microfluidic devices: a review. Int. J. Mol. Sci. 22 (2021), 1–26, 10.3390/ijms22042011.
Amirifar, L., et al. Droplet-based microfluidics in biomedical applications. Biofabrication, 14, 2022, 022001, 10.1088/1758-5090/ac39a9.
Dispas, A., et al. Microchip electrophoresis: a suitable analytical technique for pharmaceuticals quality control? A critical review. TrAC Trends Anal. Chem. (Reference Ed.), 139, 2021, 116266, 10.1016/j.trac.2021.116266.
Mohamadi, M.R., et al. Microchip electrophoresis profiling of Aβ peptides in the cerebrospinal fluid of patients with Alzheimer's disease. Methods Mol. Biol. 1855 (2019), 327–340, 10.1007/978-1-4939-8793-1_28.
Mesbah, K., et al. Neutral polymers as coatings for the high resolution electrophoretic separation of AB peptides on glass microchip. Analyst, 2014.
Wang, D., et al. A simple and sensitive paper-based bipolar electrochemiluminescence biosensor for detection of oxidase-substrate biomarkers in serum. J. Electrochem. Soc. 165 (2018), B361–B369, 10.1149/2.0551809jes.
Liu, C., et al. A colorimetric assay system for dopamine using microfluidic paper-based analytical devices. Talanta 194 (2019), 171–176, 10.1016/j.talanta.2018.10.039.
Manbohi, A., et al. Sensitive and selective detection of dopamine using electrochemical microfluidic paper-based analytical nanosensor. Sens. Bio-Sensing Res., 23, 2019, 100270, 10.1016/j.sbsr.2019.100270.
Nishat, S., et al. Paper-based microfluidics: simplified fabrication and assay methods. Sensor. Actuator. B Chem., 336, 2021, 129681, 10.1016/j.snb.2021.129681.
Ozer, T., et al. Advances in paper-based analytical devices. Annu. Rev. Anal. Chem. 13 (2020), 85–109, 10.1146/annurev-anchem-061318-114845.
Lim, H., et al. Fabrication, flow control, and applications of microfluidic paper-based analytical devices. Molecules 24 (2019), 1–32, 10.3390/molecules24162869.
Koklu, A., et al. Microfluidic integrated organic electrochemical transistor with a nanoporous membrane for amyloid-β detection. ACS Nano 15 (2021), 8130–8141, 10.1021/acsnano.0c09893.
Seo, K.D., et al. Microfluidic neurotransmitters sensor in blood plasma with mediator-immobilized conducting polymer/N, S-doped porous carbon composite. Sensor. Actuator. B Chem., 313, 2020, 128017, 10.1016/j.snb.2020.128017.
Costa, B.M.D.C., et al. Microchip electrophoresis and electrochemical detection: a review on a growing synergistic implementation. Electrochim. Acta, 391, 2021, 138928, 10.1016/j.electacta.2021.138928.
Tang, J., et al. Optical-switch-enabled microfluidics for sensitive multichannel colorimetric analysis. Anal. Chem. 93 (2021), 6784–6791, 10.1021/acs.analchem.1c00674.
Qin, X., et al. Microfluidic paper-based chips in rapid detection: current status, challenges, and perspectives. TrAC Trends Anal. Chem. (Reference Ed.), 143, 2021, 116371, 10.1016/j.trac.2021.116371.
Fernandes, G.M., et al. Novel approaches for colorimetric measurements in analytical chemistry – a review. Anal. Chim. Acta 1135 (2020), 187–203, 10.1016/j.aca.2020.07.030.
Shariati, S., Khayatian, G., The colorimetric and microfluidic paper-based detection of cysteine and homocysteine using 1,5-diphenylcarbazide-capped silver nanoparticles. RSC Adv. 11 (2021), 3295–3303, 10.1039/d0ra08615k.
Kudo, H., et al. Microfluidic paper-based analytical devices for colorimetric detection of lactoferrin. SLAS Technol 25 (2020), 47–57, 10.1177/2472630319884031.
Sarbu, M., et al. Developments and applications of separation and microfluidics methods coupled to electrospray mass spectrometry in glycomics of nervous system gangliosides. Electrophoresis, 42, 2021, 10.1002/elps.202000236.
Adams, K.J., et al. Capillary electrophoresis-high resolution mass spectrometry for measuring in vivo arginine isotope incorporation in Alzheimer's disease mouse models. J. Am. Soc. Mass Spectrom. 32 (2021), 1448–1458, 10.1021/jasms.1c00055.
Swiner, D.J., et al. Applications of mass spectrometry for clinical diagnostics: the influence of turnaround time. Anal. Chem. 92 (2020), 183–202, 10.1021/acs.analchem.9b04901.
Ha, N.S., et al. Faster, better, and cheaper: harnessing microfluidics and mass spectrometry for biotechnology. RSC Chem. Biol. 2 (2021), 1331–1351, 10.1039/d1cb00112d.
Wang, et al. Point-of-care diagnostics for infectious diseases: from mmethods to devices. Nano Today, 37, 2021, 10.1016/j.nantod.2021.101092.
Cameron, T., et al. Review of design considerations for brain-on-a-chip models. Micromachines, 12, 2021, 10.3390/mi12040441.
Rovira, M., et al. Hybrid technologies combining solid-state sensors and paper/fabric fluidics for wearable analytical devices. Biosensors 11 (2021), 1–16, 10.3390/bios11090303.
Hou, Y., et al. Recent advances and applications in paper-based devices for point-of-care testing. J. Anal. Test, 2022, 10.1007/s41664-021-00204-w.
Sun, Y., Microfluidic Capillary Electrophoresis Chip Techniques: Theory and Different Separation Modes in Multidisciplinary Microfluidic and Nanofluidic Lab-On-A-Chip. 2022, 10.1016/b978-0-444-59432-7.00002-9.
Sandlin, Z.D., et al. Microfluidic electrophoresis chip coupled to microdialysis for in vivo monitoring of amino acid. Neurotransmitters 77 (2005), 7702–7708.
Ren, K., et al. Materials for microfluidic chip fabrication. Acc. Chem. Res. 46 (2013), 2396–2406, 10.1021/ar300314s.
Vera, D., et al. Engineering tissue barrier models on hydrogel microfluidic platforms. ACS Appl. Mater. Interfaces 13 (2021), 13920–13933, 10.1021/acsami.0c21573.
Ferro, M.P., et al. Materials for blood brain barrier modeling in vitro. Mater. Sci. Eng. R Rep., 140, 2020, 100522, 10.1016/j.mser.2019.100522.
Lovett, M.L., et al. Innovations in 3D tissue models of human brain physiology and diseases. Adv. Funct. Mater. 30 (2020), 1–27, 10.1002/adfm.201909146.
Mofazzal Jahromi, M.A., et al. Microfluidic brain-on-a-chip: perspectives for mimicking neural system disorders. Mol. Neurobiol. 56 (2019), 8489–8512, 10.1007/s12035-019-01653-2.
Kadry, H., et al. A Blood – Brain Barrier Overview on Structure, Function, Impairment, and Biomarkers of Integrity, Fluids Barriers CNS. 2020, 1–24, 10.1186/s12987-020-00230-3.
Clarke, G.A., et al. Advancement of sensor integrated organ-on-chip devices. Sensors 21 (2021), 1–44, 10.3390/s21041367.
Zhu, Y., et al. State of the art in integrated biosensors for organ-on-a-chip applications. Curr. Opin. Biomed. Eng., 19, 2021, 100309, 10.1016/j.cobme.2021.100309.
Ferrari, E., et al. Integrating biosensors in organs-on-chip devices: a perspective on current strategies to monitor microphysiological systems. Biosensors, 10, 2020, 10.3390/bios10090110.
Jagtiani, E., et al. In vitro blood brain barrier models: an overview. J. Contr. Release 343 (2022), 13–30, 10.1016/j.jconrel.2022.01.011.
Liang, Y., Yoon, J.Y., In situ sensors for blood-brain barrier (BBB) on a chip. Sensors and Actuators Reports, 3, 2021, 10.1016/j.snr.2021.100031.
Reyes, D.R., et al. Accelerating innovation and commercialization through standardization of microfluidic-based medical devices. Lab Chip 21 (2021), 9–21, 10.1039/d0lc00963f.
Dekker, S., et al. Standardized and modular microfluidic platform for fast Lab on Chip system development. Sensor. Actuator. B Chem. 272 (2018), 468–478, 10.1016/j.snb.2018.04.005.